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Background
Antibiotics and antibiotics resistance genes have been tra-
ditionally used for the selection and maintenance of
recombinant plasmids in hosts such as E. coli. Although a
powerful selection tool, their use has been considered
unacceptable in many areas of biotechnology by regula-
tory authorities. Indeed, there is much international scien-
tific and regulatory focus on this issue [1]. For instance,
the use of selection markers that confer resistance to anti-
biotics in vaccine plasmids may introduce the risk of
transforming the patient's microflora and spread resist-
ance genes. Moreover, in recombinant protein production
for therapeutic use, the antibiotic must be eliminated
from the final product. Another problem arises from the
potential loss of selective pressure as a result of antibiotic
degradation i.e. ampicillin can be degraded by β-lactama-
ses in less than 30 minutes in high cell density cultures
[2].
In this work, an alternative approach to prevent plasmid
loss based on an amino acid auxotrophy complementa-
tion has been developed. A glycine-auxotrophic strain of
E. coli M15 has been created using PCR products [3]. This
strain contains an internal deletion of the glyA gene,
which encodes for serine hydroxymethyl transferase
(SHMT), an enzyme involved in the main glycine biosyn-
thesis pathway in E. coli [4]. As a result, the glyA- strain can
not synthesize glycine and, therefore, needs an external
source of glycine or a genetic source of SHMT for growing
on a defined medium. The construction of a plasmid
selection system derived from the commercial vector
pQE40 (QIAGEN) with glyA under the control of the con-
stitutive weak promoter P3 [5], as well as its evaluation in
batch and fed-batch cultures for expressing ramnulose 1-
phophate aldolase (RhuA) as a model for recombinant
protein production has been evaluated.
Results
Disruption of the glyA gene in E. coli M15 was accom-
plished using a directed knockout gene method employ-
ing PCR products through homologous recombination
[3]. The phenotype of the new strain M5ΔglyA was tested
on defined medium cultures with and without glycine,
confirming the auxotrophy for glycine.
By using SOE-PCR [6], the glyA gene (referred here and
after as β fragment) from E. coli K-12 was fused to the
weak constitutive promoter P3 (referred here and after as
α fragment). The fusion αβ product was cloned into
pQErham, a pQE40-derived vector for RhuA overexpres-
sion [7]. The resulting complementation vector, pQEα
βrham (figure 1), was used to transform the E. coli M15
ΔglyA host.
Erlenmeyers cultures with glycine-auxotrophic strain M15
ΔglyA transformed with the complementation expression
plasmid can grow in defined medium adding neither gly-
cine nor ampicillin. This indicated that the plasmid is
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ating an endogenous source of glycine. SDS-PAGE of sol-
uble cytosolic proteins under non-inducing conditions
indicated that SMHT was not being overexpressed.
The capacity of the new complementation system for pro-
ducing the recombinant RhuA was compared to that of
the conventional selection system based on antibiotic
resistance (E. coli M15 pQErham). Induction with IPTG
resulted in high overexpression of recombinant RhuA lev-
els in E. coli M15ΔglyA/pQEαβrham. However, such levels
were slightly lower than those obtained in the conven-
tional system. SDS-PAGE analyses of cell extracts revealed
significantly higher expression levels (compared with
non-inducing conditions) of a protein of about 45 kDa,
corresponding to SHMT. This suggested that the down-
stream orientation of αβ fragment in relation to the strong
T5 promoter could cause a read-through of RhuA gene in
the presence of IPTG, i.e. resulting in higher SHMT expres-
sion levels. This phenomenon could exert a metabolic
burden on the host cell, resulting in lower specific RhuA
activity levels.
High cell density fed-batch cultures using the novel com-
plementation system were performed using an exponen-
tial feeding profile strategy analogous to that previously
developed for the conventional system [7]. In particular, a
fed-batch cultivation with a controlled specific growth
rate of 0.2 h-1 (final DO600 nm = 185) was performed with-
out ampicillin. Induction with IPTG allowed obtaining
high RhuA production (28483 U l-1) and productivity
(1636 U l-1 h-1) levels.
Diagram of the complementation vector pQEαβrhamFigure 1
Diagram of the complementation vector pQEαβrham.
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Conclusion
The new selection maker based on a glycine-auxotrophy
strain plus a plasmid harboring the glyA gene under the
P3 weak promoter is a promising tool, not only for recom-
binant protein production, but also for vaccine plasmids
production processes where antibiotics can not be present
in the medium formulation. Besides, the use of a chemi-
cally defined medium avoids the risk of employing com-
ponents of animal origin that may contain viruses or
prions [1], increasing the safety level of the system for
industrial processes.
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